首頁 > 市場調查報告書 > 醫療設備

e保健

市場調查報告書

商品編碼

1534415

日本健康科技市場：依科技、競爭格局、應用、最終用戶、趨勢分析、競爭格局、預測，2019-2030

Japan HealthTech Market, By Technology; By Component; By Application; By End User, Trend Analysis, Competitive Landscape & Forecast, 2019-2030

出版日期: 2024年07月01日 | 出版商:

Blueweave Consulting | 英文 200 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

日本健康科技市場規模將以6.16%的複合年成長率大幅擴張，2030年將超過6.9512億美元

由於都市區對醫療和護理的需求不斷增加以及醫療保健領域的勞動力短缺，日本的健康科技市場正在蓬勃發展。

領先的策略諮詢和市場研究公司 BlueWeave Consulting 在最近的一項研究中估計，2023 年日本健康科技市場規模為 3.4648 億美元。 BlueWeave 預測，在 2024 年至 2030 年的預測期內，日本健康科技市場規模將以 6.16% 的複合年成長率擴大，到 2030 年將達到 6.9512 億美元。日本人口老化以及穿戴式裝置和行動醫療行動醫療等醫療保健技術的不斷湧現是日本醫療保健技術市場的主要促進因素。在預測期內，日本健康科技市場也預計將受到護理和醫療領域勞動力嚴重短缺的推動。

機會：糖尿病和其他慢性病的高盛行率

日本健康科技市場按應用細分為循環系統、糖尿病、神經科、睡眠呼吸中止症、腫瘤學等。由於日本慢性病的高盛行率，糖尿病細分市場佔了最大的市場。根據美國衛生研究院的數據，目前約有 13.5% 的日本人口患有第 2 型糖尿病（葡萄糖耐受不良）。醫療保健技術透過連續血糖監測 (CGM) 系統、智慧胰島素筆、即時健康資料、定性低血糖警報等促進更好的糖尿病管理，幫助醫療保健提供者做出明智的決策。

地緣政治緊張局勢加劇對日本醫療科技市場的影響

地緣政治緊張局勢升級可能會擾亂日本的醫療科技市場。由於以色列提供的技術資產，日本和以色列在健康科技領域有著密切的關係。然而，反以色列分裂運動日益興起，可能會破壞兩國之間的潛在合作。缺乏人力和資金是阻礙以色列科技業營運的另一個因素，這可能對日本醫療科技市場產生直接影響並限制其擴張。

日本健康科技市場

按細分市場分類的覆蓋範圍

日本健康科技市場：依最終用戶分類

按最終用戶分類，日本醫療保健市場分為醫療保健提供者、醫療保健付款人、醫療保健消費者、製藥公司等。醫療消費領域主導日本健康科技市場。此細分市場的成長主要歸因於健康技術設備的不斷推出以及患者照護服務的可用性和可及性的提高。醫療保健在獲得醫療服務方面為患者提供了許多便利，例如遠端監控和獲取健康資訊。患者可以遠端追蹤並與醫療專業人員共用他們的健康狀況，這是市場成長的主要推動力。

競爭格局

在日本健康科技市場營運的主要企業包括 Allm Inc.、M3, Inc.、Omron、Whill、FiNC、CureApp、AI Medical Service、Awarefy 和 iCARE。為了進一步增加市場佔有率，這些公司正在採取各種策略，例如併購、合作、合資、授權合約和新產品發布。

該報告的詳細分析提供了有關日本成長潛力、未來趨勢和健康技術市場的資訊。它還涵蓋了推動市場總規模預測的因素。該報告致力於提供日本健康科技市場的最新技術趨勢和產業見解，並協助決策者做出明智的策略決策。此外，我們也分析了市場的成長動力、挑戰和競爭力。

產業價值鏈分析
DROC分析
- 生長促進因子
  - 日本快速老化
  - 都市區醫療、護理需求不斷增加
  - 醫療、護理領域人力資源短缺
  - COVID-19 大流行加速了對數位健康解決方案的需求
- 抑制因素
  - 數位醫療解決方案報銷系統不成熟
  - 老年人收入有限，因此很難將解決方案收益
  - 語言障礙。大多數人不會說英語
- 機會
  - 遠端醫療、電子處方箋和數位健康應用程式報銷將改變遊戲規則
  - 健康和預防醫學領域很有吸引力，因為人們願意自掏腰包。
  - 日本人人壽保險公司正在投資數位健康解決方案並進行併購
  - 與美國的監管協調將放寬醫療設備的市場准入
- 任務
  - 平衡技術進步與患者參與並了解當地議題和價值提案
  - 開發適合日本市場的創新且盈利的經營模式
  - 尋找合適的當地合作夥伴進行分銷、促銷和市場進入
  - 了解監理核准流程和報銷制度
科技進步/最新趨勢
法律規範
波特五力分析

第4章日本健康科技市場：行銷策略

第5章日本健康科技市場概況

2019-2030年市場規模及預測
- 按金額
市場佔有率及預測
- 依技術
  - 數位醫療系統
  - 健康分析
  - 醫療資訊技術
  - 行動醫療（行動醫療）
  - 遠端醫療
- 按成分
  - 硬體
  - 軟體
  - 服務
- 按用途
  - 心臟病
  - 糖尿病
  - 神經
  - 睡眠呼吸中止症
  - 瘤
  - 其他
- 按最終用戶
  - 醫療服務提供方
  - 醫療保健付款人
  - 醫療保健消費者
  - 製藥公司
  - 其他

第6章競爭狀況

主要企業名單及其範圍
2023年日本健康科技公司市場佔有率分析
透過管理參數進行競爭基準化分析
主要策略發展（合併、收購、聯盟）

第7章地緣政治緊張局勢加劇對日本醫療科技市場的影響

第8章公司簡介（公司簡介、財務矩陣、競爭格局、關鍵人員、主要競爭對手、聯絡方式、策略展望、SWOT分析）

Allm Inc.
M3, Inc.
Omron
Whill
FiNC
CureApp
AI Medical Service
Awarefy
iCARE
其他主要企業

第9章主要戰略建議

第10章調查方法

簡介目錄圖表

Product Code: BWC24490

Japan HealthTech Market Size Expands at Significant CAGR of 6.16% to Surpass Value of USD 695.12 Million by 2030

Japan HealthTech Market is flourishing because of an increasing demand for medical and nursing care in urban areas and labor shortage in the healthcare care sector.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Japan HealthTech Market size at USD 346.48 million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects Japan HealthTech Market size to expand at a CAGR of 6.16% reaching a value of USD 695.12 million by 2030. The country's aging population and the increasing introduction of healthcare technology, such as wearables and mHealth applications, are key drivers of the Japan Healthtech Market. Over the forecast period, Japan Healthtech Market is also expected to be driven by a severe labor shortage in the nursing and medical care sectors.

Opportunity: High Prevalence of diabetes and other chronic diseases

Japan HealthTech Market, based on application, is segmented into cardiology, diabetes, neurology, sleep apnea, oncology, and others. The diabetic segment holds the largest share in the market owing to the high prevalence of the chronic disease in Japan. According to the National Institutes of Health, currently, type 2 diabetes, or impaired glucose tolerance, affects around 13.5% of the population in Japan. Healthtech facilitates better management of diabetes through continuous glucose monitoring (CGM) system, smart insulin pens, real-time health data, qualitative hypoglycemia alarms, and others, which allows healthcare providers to make informed decisions.

Impact of Escalating Geopolitical Tensions on Japan HealthTech Market

The escalating geopolitical tensions may disrupt the Japan Healthtech market. Japan and Israel have close ties in the healthtech sector owing to the technological assets offered by the latter. However, divestment campaigns against Israel are being launched, which might impede potential collaboration between the two nations. Lack of manpower and funding is another factor impeding Israel's technology sector operations, which might have a direct impact on Japan Healthtech Market and may restrict its expansion.

Japan HealthTech Market

Segmental Coverage

Japan HealthTech Market - By End User

Based on end user, Japan HealthTech Market is segmented into healthcare providers, healthcare payers, healthcare consumers, pharmaceutical companies, and others. The healthcare consumers segment dominates Japan Healthtech Market. The growth of the segment is mainly attributed to the increasing launches of healthtech devices and the rising availability and accessibility of patient-care services. Healthtech offers many conveniences to patients in terms of healthcare accessibility, such as remote monitoring and access to health information. Patients can track and share their vitality with their healthcare professionals remotely, which acts as a major driving force for market growth.

Competitive Landscape

Major players operating in Japan HealthTech Market include Allm Inc., M3, Inc., Omron, Whill, FiNC, CureApp, AI Medical Service, Awarefy, and iCARE. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and Japan HealthTech Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Japan HealthTech Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

1. Research framework

1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation

2. Executive Summary

3. Japan HealthTech Market Insights

3.1. Industry Value Chain Analysis
3.2. DROC Analysis
- 3.2.1. Growth Drivers
  - 3.2.1.1. Japan's Rapidly Aging Population
  - 3.2.1.2. Increased Demand for Medical and Nursing Care in Urban Areas
  - 3.2.1.3. Labor Shortage in the Medical and Nursing Care Sectors
  - 3.2.1.4. COVID-19 Pandemic has Accelerated the Need for Digital Health Solutions
- 3.2.2. Restraints
  - 3.2.2.1. Immature Reimbursement System for Digital Health Solutions
  - 3.2.2.2. Elderly Population has Limited Income, Making it Difficult to Monetize Solutions
  - 3.2.2.3. Language Barrier, as Most People don't Speak English
- 3.2.3. Opportunities
  - 3.2.3.1. Telemedicine, E-Prescriptions, and Reimbursement for Digital Health Apps will be Game-Changers
  - 3.2.3.2. Wellness and Preventive Medicine Segments are Attractive, as People are Willing to Pay Out-Of-Pocket
  - 3.2.3.3. Japanese Life Insurers are Investing in Digital Health Solutions and Conducting M&A
  - 3.2.3.4. Harmonization of Regulations with the U.S. is Making Market Entry Easier for Medical Devices
- 3.2.4. Challenges
  - 3.2.4.1. Balancing Tech Push with Patient Pull and Understanding the Local Problem and Value Proposition
  - 3.2.4.2. Developing Innovative, Profitable Business Models suited to the Japanese Market
  - 3.2.4.3. Finding the Right Local Partner for Distribution, Promotion, and Market Access
  - 3.2.4.4. Navigating the Regulatory Approval Process and Reimbursement System
3.3. Technological Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter's Five Forces Analysis
- 3.5.1. Bargaining Power of Suppliers
- 3.5.2. Bargaining Power of Buyers
- 3.5.3. Threat of New Entrants
- 3.5.4. Threat of Substitutes
- 3.5.5. Intensity of Rivalry

4. Japan HealthTech Market: Marketing Strategies

5. Japan HealthTech Market Overview

5.1. Market Size & Forecast, 2019-2030
- 5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
- 5.2.1. By Technology
  - 5.2.1.1. Digital Health Systems
  - 5.2.1.2. Health Analytics
  - 5.2.1.3. Health Information Technology
  - 5.2.1.4. mHealth
  - 5.2.1.5. Telehealthcare
- 5.2.2. By Component
  - 5.2.2.1. Hardware
  - 5.2.2.2. Software
  - 5.2.2.3. Services
- 5.2.3. By Application
  - 5.2.3.1. Cardiology
  - 5.2.3.2. Diabetes
  - 5.2.3.3. Neurology
  - 5.2.3.4. Sleep Apnea
  - 5.2.3.5. Oncology
  - 5.2.3.6. Others
- 5.2.4. By End User
  - 5.2.4.1. Healthcare Providers
  - 5.2.4.2. Healthcare Payers
  - 5.2.4.3. Healthcare Consumers
  - 5.2.4.4. Pharmaceutical Companies
  - 5.2.4.5. Others

6. Competitive Landscape

6.1. List of Key Players and Their Range
6.2. Japan HealthTech Company Market Share Analysis, 2023
6.3. Competitive Benchmarking, By Operating Parameters
6.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships)

7. Impact of Escalating Geopolitical Tensions on Japan HealthTech Market Industry

8. Company Profiles (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook, and SWOT Analysis)

8.1. Allm Inc.
8.2. M3, Inc.
8.3. Omron
8.4. Whill
8.5. FiNC
8.6. CureApp
8.7. AI Medical Service
8.8. Awarefy
8.9. iCARE
8.10. Other prominent players

9. Key Strategic Recommendations

10. Research Methodology

10.1. Qualitative Research
- 10.1.1. Primary & Secondary Research
10.2. Quantitative Research
10.3. Market Breakdown & Data Triangulation
- 10.3.1. Secondary Research
- 10.3.2. Primary Research
10.4. Breakdown of Primary Research Respondents
10.5. Assumption & Limitation

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.

簡介目錄圖表